Enzyme-linked immunosorbent assay (ELISA) for the specific detection of apoptotic cells and its application to rapid drug screening

Journal of Immunological Methods

Volumn 253, Issue 1-2, 2001, Pages 133-144

  Frankfurt, Oskar S ^a,b   Krishan, Awtar ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Apostain Inc   (United States)

Author keywords

Apoptosis; Cytotoxicity; DNA; Drug screening; ELISA; Single stranded

Indexed keywords

CISPLATIN; ETOPOSIDE; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; SINGLE STRANDED DNA; STAUROSPORINE;

ANALYTIC METHOD; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL DEATH; CYTOTOXICITY; DNA DENATURATION; DRUG ABSORPTION; DRUG MECHANISM; DRUG SCREENING; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; DNA, SINGLE-STRANDED; DRUG EVALUATION, PRECLINICAL; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FORMAMIDES; HUMANS; NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0035400499     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(01)00387-8     Document Type: Article

References (28)

1. Condensation of chromatin in apoptotic thymocytes shows a specific structural change
2. A high throughput colorimetric cell proliferation assay for the identification of human cytomegalovirus inhibitors
3. Thermodynamic effects of formamide on DNA stability
4. NCI's anticancer drug screening program may not be selecting for clinically active compounds
5. Apoptosis, p53, and tumor cell sensitivity to anticancer agents
6. A cautionary note on the use of TUNEL to determine apoptosis
7. Internucleososmal DNA cleavage triggered by plasma membrane damage during necrotic cell death
8. Decreased DNA stability in cells treated with alkylating agents
9. Detection of apoptosis in leukemic and breast cancer cells with monoclonal antibody to single-stranded DNA
10. Identification of apoptotic cells by formamide-induced DNA denaturation in condensed chromatin
11. Pleiotropic drug resistance and survival advantage in leukemic cells with diminished apoptotic response
12. Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis
13. In situ detection of fragmented DNA (TUNEL) fails to discriminate among apoptosis, necrosis and autolytic cell death: A cautionary note
14. Apoptosis and the dilemma of cancer chemotherapy
15. Significance of myocytes with positive DNA in situ nick end labeling (TUNEL) in hearts with dilated cardiomyopathy: Not apoptosis but DNA repair
16. The application of high-throughput screening to novel lead discovery
17. Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival
18. Denaturation of deoxyribonucleic acid by formamide
19. Relationship of mitotic arrest and apoptosis to antitumor effect of paxitaxel
20. Cell-based screen for antimitotic agents and the identification of the analogues of rhizoxin, eleutherobin, and paxitaxel in natural extracts
21. High-throughput and ultra-high-throughput screening: Solution and cell-based approaches
22. Association of tissue specific histone with deoxyribonucleic acid. Thermal denaturation of native, partially dehistonized and reconstituted chromatins
23. Cytochemical methods for the detection of apoptosis
24. Apoptotic cell death correlates with chemosensitivity, independent of p53 and Bcl-2
25. Apoptosis in relevant clinical situations: Contribution of apoptosis to myocardial infarction
26. BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells
27. Condensed matter in cell death
28. Immunodetection of histone epitopes correlates with early stages of apoptosis in activated human peripheral T lymphocytes